Denmark might need to extend its medical cannabis trial plans in order for the government to conduct a mandated midterm evaluation of the pilot program, Health Minister Magnus Heunicke said.
The four-year program launched in 2018, and a formal evaluation is required to take place in 2020.
The number of patients who accessed medical cannabis via the scheme saw virtually no growth in recent quarters because of a combination of pricey imports and supply issues.
Heunicke said it would be difficult to thoroughly access the trial program since domestically produced medical marijuana, which remains behind schedule, has not yet reached patients.
Stakeholders have been meeting with Heunicke as well as the parliamentary health committee to share their views on the program’s future.